[Pharmacology of antirheumatic drugs].
D000255:Adenosine Triphosphate / Q000096:biosynthesis; D000700:Analgesics / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology* / Q000627:therapeutic use; D002490:Central Nervous System / Q000187:drug effects; D055598:Chemical Phenomena; D002621:Chemistry; D003238:Connective Tissue / Q000187:drug effects; D004487:Edema / Q000188:drug therapy / Q000378:metabolism; D005439:Flufenamic Acid / Q000494:pharmacology / Q000627:therapeutic use; D006025:Glycosaminoglycans / Q000096:biosynthesis; D006801:Humans; D007213:Indomethacin / Q000494:pharmacology / Q000627:therapeutic use; D008528:Mefenamic Acid / Q000494:pharmacology / Q000627:therapeutic use; D010113:Oxyphenbutazone / Q000494:pharmacology / Q000627:therapeutic use; D010653:Phenylbutazone / Q000494:pharmacology / Q000627:therapeutic use; D010913:Pituitary-Adrenal System / Q000187:drug effects; D051381:Rats; D012216:Rheumatic Diseases / Q000188:drug therapy; D012459:Salicylates / Q000494:pharmacology / Q000627:therapeutic use
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D006025:Glycosaminoglycans; D012459:Salicylates; D008528:Mefenamic Acid; D005439:Flufenamic Acid; D000255:Adenosine Triphosphate; D010653:Phenylbutazone; D010113:Oxyphenbutazone; D007213:Indomethacin
Pharmakologie der Antirheumatica.